Silva A. Ribeiro
Sao Paulo, SP 01308050, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.
Journal: SAGE open medical case reports
Published: December 15, 2021
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome.
Journal: JCO global oncology
Published: July 16, 2021
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.
Journal: Cancers
Published: October 26, 2020
Takotsubo syndrome induced by brachytherapy in a patient with endocervical adenocarcinoma.
Journal: Cardio-oncology (London, England)
Published: September 05, 2020
Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient.
Journal: NPJ precision oncology
Published: August 04, 2020
Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma.
Journal: Clinical lung cancer
Published: May 12, 2020
Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 10, 2019
Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.
Journal: Case reports in oncological medicine
Published: January 09, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026